BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31389610)

  • 1. LINC00702 accelerates the progression of ovarian cancer through interacting with EZH2 to inhibit the transcription of KLF2.
    Wang L; Ye TY; Wu H; Chen SY; Weng JR; Xi XW
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):201-208. PubMed ID: 31389610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC01232 Promotes Gastric Cancer Proliferation through Interacting with EZH2 to Inhibit the Transcription of KLF2.
    Liu J; Li Z; Yu G; Wang T; Qu G; Wang Y
    J Microbiol Biotechnol; 2021 Oct; 31(10):1358-1365. PubMed ID: 34409953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC01210 accelerates proliferation, invasion and migration in ovarian cancer through epigenetically downregulating KLF4.
    Zhang C; Liu J; Zhang Y; Luo C; Zhu T; Zhang R; Yao R
    Biomed Pharmacother; 2019 Nov; 119():109431. PubMed ID: 31514068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA AFAP1-AS1 promotes proliferation and migration of gastric cancer by downregulating KLF2.
    Yuan XH; Li J; Cao Y; Jie ZG; Zeng YF
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):673-680. PubMed ID: 32016968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer.
    Bai Z; Wu Y; Bai S; Yan Y; Kang H; Ma W; Zhang J; Gao Y; Hui B; Ma H; Li R; Zhang X; Ren J
    J Cell Mol Med; 2020 Jul; 24(13):7479-7489. PubMed ID: 32420685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
    Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA DANCR aggravates the progression of ovarian cancer by downregulating UPF1.
    Pei CL; Fei KL; Yuan XY; Gong XJ
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10657-10663. PubMed ID: 31858532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA ATB promotes ovarian cancer tumorigenesis by mediating histone H3 lysine 27 trimethylation through binding to EZH2.
    Chen XJ; An N
    J Cell Mol Med; 2021 Jan; 25(1):37-46. PubMed ID: 33336896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
    Meng XF; Zhao LY; Chu XF
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA SNHG1 promotes bladder cancer progression by upregulating EZH2 and repressing KLF2 transcription.
    Min J; Ma J; Wang Q; Yu D
    Clinics (Sao Paulo); 2022; 77():100081. PubMed ID: 36087568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4.
    Sun D; Fan XH
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2345-2352. PubMed ID: 30964158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
    Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
    Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC01116 promotes proliferation, invasion and migration of osteosarcoma cells by silencing p53 and EZH2.
    Zhang ZF; Xu HH; Hu WH; Hu TY; Wang XB
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6813-6823. PubMed ID: 31486480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of cell division cycle-associated protein 7 (CDCA7) suppresses cell proliferation, arrests cell cycle of ovarian cancer, and restrains angiogenesis by modulating enhancer of zeste homolog 2 (EZH2) expression.
    Cai C; Peng X; Zhang Y
    Bioengineered; 2021 Dec; 12(1):7007-7019. PubMed ID: 34551671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The carcinogenic complex lncRNA DUXAP8/EZH2/LSD1 accelerates the proliferation, migration and invasion of colorectal cancer.
    Gong A; Huang Z; Ge H; Cai Y; Yang C
    J BUON; 2019; 24(5):1830-1836. PubMed ID: 31786844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FBXL19-AS1 aggravates the progression of hepatocellular cancer by downregulating KLF2.
    Chen Y; Yang L
    J BUON; 2021; 26(4):1333-1339. PubMed ID: 34564989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA CACS15 accelerates the malignant progression of ovarian cancer through stimulating EZH2-induced inhibition of APC.
    Liu Y; Sun J; Yu J; Ge W; Xiao X; Dai S; Xiang Q
    Am J Transl Res; 2019; 11(10):6561-6568. PubMed ID: 31737207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC00202 attenuates the progression of gastric cancer via suppressing expression level of KLF2.
    Xu Q; Qiao S; Liu L; Xu J; Yang L; Chen X; Yang L; Yao B
    J BUON; 2021; 26(2):506-512. PubMed ID: 34076999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer.
    Liu Z; Chen Z; Fan R; Jiang B; Chen X; Chen Q; Nie F; Lu K; Sun M
    Mol Cancer; 2017 Apr; 16(1):82. PubMed ID: 28441948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.